Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2

被引:9
|
作者
Gagnon, SJ
Turner, RV
Shiue, MG
Damirjian, M
Biddison, WE
机构
[1] NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Princeton BioMol Corp, Langhorne, PA 19047 USA
关键词
T cell receptors; cytotoxic T lymphocytes; cross-reactivity;
D O I
10.1016/j.molimm.2005.02.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have shown that individual TCRs are able to effectively recognize multiple peptide/MHC complexes that have varying degrees of structural diversity. These TCR cross-reactivities have usually been demonstrated by using peptides that have different amino acid sequences. To further examine the extent to which TCRs can accommodate structurally diverse ligands, we analyzed human TCR cross-reactivity to eight structurally distinct haptens that are coupled to the HLA-A2-binding Tax peptide with a lysine substitution at position 5 (Tax-5K, LLFG[K-hapten]PVYV). The results demonstrate that 71% percent of the haptenated-peptide-induced CTL lines could cross-react on at least one other hapten. We compared the effects of HLA-A2 mutants with substitutions at known TCR contact sites for recognition by hapten-cross-reactive CTL. Recognition of the A2 mutants was remarkably similar whether they were presenting the immunizing or the cross-reactive peptide, indicating that similar amino acid contacts are made by the TCR during recognition of both complexes. Thus, hapten cross-reactivity is apparently accomplished without major adjustments to the interaction between the TCR and the surface of the HLA-A2 molecule. Collectively, these results suggest that TCRs possess the molecular flexibility to accommodate very structurally diverse ligands while retaining conserved interactions with the surface of the MHC molecule. Published by Elsevier Ltd.
引用
收藏
页码:346 / 356
页数:11
相关论文
共 50 条
  • [21] T cell receptor cross-reactivity expanded by dramatic peptide–MHC adaptability
    Timothy P. Riley
    Lance M. Hellman
    Marvin H. Gee
    Juan L. Mendoza
    Jesus A. Alonso
    Kendra C. Foley
    Michael I. Nishimura
    Craig W. Vander Kooi
    K. Christopher Garcia
    Brian M. Baker
    Nature Chemical Biology, 2018, 14 : 934 - 942
  • [22] Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor
    Kumar, Amit
    Delogu, Francesco
    SCIENTIFIC REPORTS, 2017, 7
  • [23] BCG-derived peptides induce T cell cross-reactivity to Sars-CoV-2 homologues
    Eggenhuizen, P. J.
    Ng, Boaz H.
    Chang, Janet
    Fell, Ashleigh L.
    Ooi, Joshua D.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [24] Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses
    Jing, Lichen
    Laing, Kerry J.
    Dong, Lichun
    Russell, Ronnie M.
    Barlow, Russell S.
    Haas, Juergen G.
    Ramchandani, Meena S.
    Johnston, Christine
    Buus, Soren
    Redwood, Alec J.
    White, Katie D.
    Mallal, Simon A.
    Phillips, Elizabeth J.
    Posavad, Christine M.
    Wald, Anna
    Koelle, David M.
    JOURNAL OF IMMUNOLOGY, 2016, 196 (05): : 2205 - 2218
  • [25] T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability
    Riley, Timothy P.
    Hellman, Lance M.
    Gee, Marvin H.
    Mendoza, Juan L.
    Alonso, Jesus A.
    Foley, Kendra C.
    Nishimura, Michael I.
    Vander Kooi, Craig W.
    Garcia, K. Christopher
    Baker, Brian M.
    NATURE CHEMICAL BIOLOGY, 2018, 14 (10) : 934 - +
  • [26] Cross-sensitization to haptens: formation of common haptenic metabolites, T cell recognition of cryptic peptides, and true T cell cross-reactivity
    Wulferink, M
    Dierkes, S
    Gleichmann, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (05) : 1338 - 1348
  • [27] Clusters of Structurally Similar MHC I HLA-A2 Molecules, Found with a New Method, Suggest Mechanisms of T-Cell Receptor Avidity
    Rashin, Alexander A.
    Jernigan, Robert L.
    BIOCHEMISTRY, 2016, 55 (01) : 167 - 185
  • [28] Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes
    Walter, JB
    Brander, C
    Mammen, M
    Garboczi, DN
    Kalams, SA
    Whitesides, GM
    Walker, BD
    Eisen, HN
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (03) : 451 - 459
  • [29] Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity
    Depta, JPH
    Altznauer, F
    Gamerdinger, K
    Burkhart, C
    Weltzien, HU
    Pichler, WJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (03) : 519 - 527
  • [30] A phosphorylated β-catenin peptide that is presented by HLA-A2 generates strong phosphospecific T cell responses against melanoma
    Obeng, Rebecca
    Le Poole, I.
    Hunt, Donald
    Engelhard, Victor
    JOURNAL OF IMMUNOLOGY, 2010, 184